BACKGROUND: The National Survey of Lead and Allergens in Housing was the first population-based study to measure indoor allergen levels in US homes. OBJECTIVE: We characterized the overall burden to multiple allergens and examined whether increased allergen levels were associated with occupants' asthma status. METHODS: This cross-sectional study surveyed a nationally representative sample of 831 housing units in 75 different locations throughout the United States. Information was collected by means of questionnaire and environmental assessment. Allergen concentrations in dust samples were assessed by using immunoassays. The following cutoff points were used to define increased allergen levels: 10 microg/g for Der p 1, Der f 1, and Can f 1; 8 microg/g for Fel d 1; 8 U/g for Bla g 1; 1.6 microg/g for mouse urinary protein; and 7 microg/g for Alternaria alternata antigens. Allergen burden was considered high when 4 or more allergens exceeded increased levels in any of the sampling locations. RESULTS: Exposure to multiple allergens was common in US homes. Of the surveyed homes, 51.5% had at least 6 detectable allergens and 45.8% had at least 3 allergens exceeding increased levels. Race, income, housing type, absence of children, and presence of smokers, pets, cockroaches, rodents, and mold/moisture-related problems were independent predictors of high allergen burden. Among atopic subjects, high allergen burden increased the odds of having asthma symptoms (odds ratio, 1.81; 95% CI, 1.04-3.15). CONCLUSION: Increased allergen levels in the home are associated with asthma symptoms in allergic individuals.
BACKGROUND: The National Survey of Lead and Allergens in Housing was the first population-based study to measure indoor allergen levels in US homes. OBJECTIVE: We characterized the overall burden to multiple allergens and examined whether increased allergen levels were associated with occupants' asthma status. METHODS: This cross-sectional study surveyed a nationally representative sample of 831 housing units in 75 different locations throughout the United States. Information was collected by means of questionnaire and environmental assessment. Allergen concentrations in dust samples were assessed by using immunoassays. The following cutoff points were used to define increased allergen levels: 10 microg/g for Der p 1, Der f 1, and Can f 1; 8 microg/g for Fel d 1; 8 U/g for Bla g 1; 1.6 microg/g for mouse urinary protein; and 7 microg/g for Alternaria alternata antigens. Allergen burden was considered high when 4 or more allergens exceeded increased levels in any of the sampling locations. RESULTS: Exposure to multiple allergens was common in US homes. Of the surveyed homes, 51.5% had at least 6 detectable allergens and 45.8% had at least 3 allergens exceeding increased levels. Race, income, housing type, absence of children, and presence of smokers, pets, cockroaches, rodents, and mold/moisture-related problems were independent predictors of high allergen burden. Among atopic subjects, high allergen burden increased the odds of having asthma symptoms (odds ratio, 1.81; 95% CI, 1.04-3.15). CONCLUSION: Increased allergen levels in the home are associated with asthma symptoms in allergic individuals.
Authors: K Huss; N F Adkinson; P A Eggleston; C Dawson; M L Van Natta; R G Hamilton Journal: J Allergy Clin Immunol Date: 2001-01 Impact factor: 10.793
Authors: Patrick J Vojta; Warren Friedman; David A Marker; Robert Clickner; John W Rogers; Susan M Viet; Michael L Muilenberg; Peter S Thorne; Samuel J Arbes; Darryl C Zeldin Journal: Environ Health Perspect Date: 2002-05 Impact factor: 9.031
Authors: Brian P Leaderer; Kathleen Belanger; Elizabeth Triche; Theodore Holford; Diane R Gold; Young Kim; Thomas Jankun; Ping Ren; Jean-ellen McSharry Je; Thomas A E Platts-Mills; Martin D Chapman; Michael B Bracken Journal: Environ Health Perspect Date: 2002-04 Impact factor: 9.031
Authors: Leslie Elliott; Samuel J Arbes; Eric S Harvey; Robert C Lee; Päivi M Salo; Richard D Cohn; Stephanie J London; Darryl C Zeldin Journal: Environ Health Perspect Date: 2006-11-07 Impact factor: 9.031
Authors: Ellen F Crain; Michelle Walter; George T O'Connor; Herman Mitchell; Rebecca S Gruchalla; Meyer Kattan; George S Malindzak; Paul Enright; Richard Evans; Wayne Morgan; James W Stout Journal: Environ Health Perspect Date: 2002-09 Impact factor: 9.031
Authors: Maksymilian Chruszcz; Anna Pomés; Jill Glesner; Lisa D Vailes; Tomasz Osinski; Przemyslaw J Porebski; Karolina A Majorek; Peter W Heymann; Thomas A E Platts-Mills; Wladek Minor; Martin D Chapman Journal: J Biol Chem Date: 2011-12-30 Impact factor: 5.157
Authors: Geoffrey A Mueller; Lars C Pedersen; Fred B Lih; Jill Glesner; Andrea F Moon; Martin D Chapman; Kenneth B Tomer; Robert E London; Anna Pomés Journal: J Allergy Clin Immunol Date: 2013-07-31 Impact factor: 10.793
Authors: L Karla Arruda; Michelle C R Barbosa; Ana Beatriz R Santos; Adriana S Moreno; Martin D Chapman; Anna Pomés Journal: Curr Allergy Asthma Rep Date: 2014-04 Impact factor: 4.806
Authors: Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash Journal: Expert Rev Respir Med Date: 2013-10-03 Impact factor: 3.772
Authors: Caroline M Percopo; Julia O Krumholz; Elizabeth R Fischer; Laura S Kraemer; Michelle Ma; Karen Laky; Helene F Rosenberg Journal: J Leukoc Biol Date: 2018-10-04 Impact factor: 4.962